Unique skills and experiences enable ChromaCode to successfully integrate life sciences and data sciences into industry-redefining ways.

Alex Dickinson

PhD, Founder and Executive Chairman

Alex is a life sciences executive with over 25 years experience leading strategic initiatives that have transformed small companies and enabled large companies to penetrate new markets. Most recently, he was the Senior Vice President of Strategic Initiatives at Illumina, Inc. where his responsibilities included working with national governments and large institutions to develop precision medicine programs for healthcare systems.

Alex Dickinson

PhD

Founder and Executive Chairman

Greg Gosch

Founder, President and Chief Executive Officer

Greg has over 20 years of management experience in the molecular diagnostics and nucleic acids research fields. He spent 9 years at Luminex, when the company grew revenues from $30 million to over $200 million. He held multiple roles including VP of Sales and Marketing, where he was responsible for global commercial operations, and VP/GM of Biosciences, where was responsible for developing novel instrument and assay products for gene expression, microRNA, newborn screening and Alzheimer’s disease.

Greg Gosch

Founder

President and Chief Executive Officer

Aditya Rajagopal

PhD, Founder and Chief Technical Officer

Aditya is the inventor of HDPCR, ChromaCode’s core technology. Previously, he was a researcher at Google[x], where he worked on novel medical imaging methods. He has expertise in thermal engineering, digital signal processing, nano-scale electronics, low-power circuit design for implantable sensors, DNA sequencing structures and techniques, and PCR devices and applications.

Aditya Rajagopal

PhD

Founder and Chief Technical Officer

Brett Brown

Vice President, Finance and Administration

Brett has over twenty years of experience in finance, corporate management, and human resources. He has worked in a broad range of industries and company sizes. His passion is helping companies with ground-breaking technology strategically expand their teams. At Luxtera, a pioneer in optics and electronic integration, he helped shape the company’s evolution from early research and development to initial revenue.

Brett Brown

Vice President

Finance and Administration

Chris MacDonald

PhD, Vice President, Operations and Data Science

Chris is an experienced engineer and manager in the life sciences industry focused on data science, product engineering and process development. Most recently, he was an engineering manager at Illumina, leading the development of processes for consumables manufacturing across several major platforms, including the HiSeqX nanopatterned flowcell which enabled the $1000 genome.

Chris MacDonald

PhD, Vice President

Operations and Data Science

Karen Menge

PhD, Vice President Research and Development

Karen has over 20 years industry experience in leadership capacities spanning research, product development, clinical affairs, regulatory, quality assurance, and operations. Her core expertise lies in the development and deployment of Molecular Diagnostic products. Most recently as Director of Programs for GSSHealth she was responsible for establishing programs for quality improvement in clinical laboratories serving HIV patients in West Africa.

Karen Menge

PhD, Vice President

Research and Development

Lynne Rollins

Treasurer and Corporate Secretary

Lynne has over 35 years’ experience in the healthcare industry in the areas of finance and business development. She is currently a CFO consultant for start-up pharmaceutical and medical device companies and has worked with 35 start-up companies over the last 15 years. Prior to that, she was with Baxter Healthcare Corporation for 19 years. Her positions at Baxter included Vice President of Business Development for the Cardiopulmonary Business of the CardioVascular Group.

Lynne Rollins

Treasurer

Corporate Secretary

Patricia Wilch

Vice President, Marketing

Patricia has 30 years of diagnostic and life science industry experience spanning research, product development, clinical affairs, regulatory affairs and commercial operations. Patricia has worked for many of the top industry leaders including Abbott, Luminex, Hologic and Qiagen, holding positions of increased leadership responsibility. Patricia has extensive commercial experience in molecular diagnostics and was a key member of one of the first product launches in the space, Abbott’s LCx Chlamydia.

Patricia Wilch

Vice President

Marketing

Paul Flook

PhD, Vice President, Software Engineering

Paul has over twenty years experience in software development and scientific research. He has directed multiple teams developing industry-leading scientific software and has published in various areas including Molecular Modeling, Bioinformatics, Genetics and Molecular Evolution. Before joining ChromaCode, Paul led the BaseSpace development team at Illumina, where he oversaw commercialization and clinical transformation of the cloud genomics platform.

Paul Flook

PhD, Vice President

Software Engineering

Board of Directors

Jim Blair

PhD

Domain Associates

Jim has been a partner of the venture capital firm Domain and Associates since the firm’s founding in 1985. Jim has more than 40 years of experience with venture and emerging growth companies. He has been involved in the creation and successful development at the board level of more than 40 life sciences ventures, including Amgen, Aurora Biosciences, Amylin Pharmaceuticals, Applied Biosystems, Cadence Pharmaceuticals, Dura Pharmaceuticals, GeneOhm Sciences, and Molecular Dynamics.

Alex Dickinson

PhD

Founder and Executive Chairman

Alex is a life sciences executive with over 25 years experience leading strategic initiatives that have transformed small companies and enabled large companies to penetrate new markets. Most recently, he was the Senior Vice President of Strategic Initiatives at Illumina, Inc. where his responsibilities included working with national governments and large institutions to develop precision medicine programs for healthcare systems.

Greg Gosch

Founder

President and Chief Executive Officer

Greg has over 20 years of management experience in the molecular diagnostics and nucleic acids research fields. He spent 9 years at Luminex, when the company grew revenues from $30 million to over $200 million. He held multiple roles including VP of Sales and Marketing, where he was responsible for global commercial operations, and VP/GM of Biosciences, where was responsible for developing novel instrument and assay products for gene expression, microRNA, newborn screening and Alzheimer’s disease.

Justin Klein

MD, JD

NEA

Justin joined NEA in 2006 and is a Partner on the healthcare team. He focuses on medical device, healthcare technology, and biopharmaceutical company investments. He serves as a director of Advanced Cardiac Therapeutics, Cartiva, FIRE1, Intact Vascular, Personal Genome Diagnostics, PhaseBio Pharmaceuticals, Relievant Medsystems, Senseonics (NYSE: SENS), VertiFlex, Vesper Medical, and VytronUS. Justin’s past board memberships and investments include CV Ingenuity (acquired by Covidien), and Nevro (NYSE: NVRO).

Aditya Rajagopal

PhD

Founder and Chief Technical Officer

Aditya is the inventor of HDPCR, ChromaCode’s core technology. Previously, he was a researcher at Google[x], where he worked on novel medical imaging methods. He has expertise in thermal engineering, digital signal processing, nano-scale electronics, low-power circuit design for implantable sensors, DNA sequencing structures and techniques, and PCR devices and applications.

Corporate Advisors

Yaser Abu-Mostafa

PhD

Caltech

Yaser is a Professor of Electrical Engineering and Computer Science at the California Institute of Technology, and Chairman of Machine Learning Consultants LLC. His main fields of expertise are machine learning and computational finance. He is the author of Amazon’s machine learning bestseller Learning from Data. His MOOC on machine learning has attracted more than two million views.

Andrea Ferreria-Gonzalez

PhD

Virginia Commonwealth University

Andrea is the Chair of the Division of Molecular Diagnostics in the Department of Pathology at the Virginia Commonwealth University Health System. She is also the director of the Molecular Diagnostics Laboratory at the VCU Health System.

Michael Frumkin

Google

Michael has been an Engineering Director at Google since 2002 where his responsibilities have ranged from managing large engineering teams responsible for most of Google’s revenue, to overseeing critical internal software infrastructure projects. Michael currently leads a Google Research team that he founded, whose primary aim is to bring Google’s expertise in machine intelligence and machine perception to bear on fundamental scientific research.

David Hillyard

PhD

ARUP

Dr. David Hillyard is Director of Molecular Infectious Disease Testing at ARUP Laboratories, a leading institution for esoteric laboratory testing, and a Professor of Pathology at the University of Utah. Dr. Hillyard is a renowned expert in infectious disease test development and utilization and has authored over 100 papers in the field. In 2014 he was inducted into the National Academy of Inventors. He currently serves as the Chair of the Infectious Disease Subdivision for the Association of Molecular Pathology.

Gregory Tsongalis

PhD

Dartmouth Hitchcock Medical Center

Greg is the Director of the Laboratory for Clinical Genomics and Advanced Technology (CGAT) at the Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center in Lebanon, NH and a Professor of Pathology at the Geisel School of Medicine at Dartmouth in Hanover, NH. He was the inaugural director of the molecular pathology laboratory at Hartford Hospital in Hartford, CT before going to Dartmouth.